Viewing Study NCT00780494


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-05-29 @ 6:13 AM
Study NCT ID: NCT00780494
Status: COMPLETED
Last Update Posted: 2025-01-14
First Post: 2008-10-23
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Sponsor: Stanford University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Stomach Cancer View
None Gastric (Stomach) Cancer View
None Neoplasm of Cardioesophageal Junction View
None Gastrointestinal Stromal Tumor (GIST) View
Keywords: